YESCARTA is a prescription medicine used to treat two types of non-Hodgkin lymphoma:

large B-cell lymphoma when your first treatment did not work or your cancer returned within a year of first treatment, OR when at least two kinds of treatment have failed to control your cancer.
follicular lymphoma when at least two kinds of treatment have failed to control your cancer.

YESCARTA is different than other cancer medicines because it is made from your own white blood cells, which have been modified to recognize and attack your lymphoma cells.

Read Less

YESCARTA is a prescription medicine...

VIEW ANOTHER INDICATION

Important Facts

Important safety information

Visit HCP Site

About Yescarta

Find a treatment center

VIEW ANOTHER INDICATION

Important Facts

Important safety information

Visit HCP Site

About Yescarta

Find a treatment center

ERROR 404 - PAGE NOT FOUND

Unfortunately, the content you're looking for isn't here. There may be a misspelling in your web address, or you may have clicked a link that no longer exists. Please navigate to the YESCARTA^® home page.

You are now leaving the YESCARTA^® (axicabtagene ciloleucel) website.

Kite is not responsible for the information contained in any of the linked sites.

Cancel

Continue

You are going to a website that contains clinical information and was created specifically for healthcare professionals. If you are not a healthcare professional and would like to remain on the patient site, please select cancel.

Cancel

Confirm

This is a definition

Definition paragraph

Close

Important Safety Information | What is the most important information I should know about YESCARTA?

What is the most important information I should know about YESCARTA?

YESCARTA may cause side effects that are life-threatening and can lead to death. Call or see your healthcare provider or get emergency help right away if you get any of the following:

Fever (100.4°F/38°C or higher)
Difficulty breathing
Chills or shaking chills
Confusion
Dizziness or lightheadedness
Severe nausea, vomiting, or diarrhea
Fast or irregular heartbeat
Severe fatigue or weakness

It is important to tell your healthcare provider that you received YESCARTA and to show them your YESCARTA Patient Wallet Card. Your healthcare provider may give you other medicines to treat your side effects.

Before getting YESCARTA, tell your healthcare provider about all your medical problems, including if you have or have had:

Neurologic problems (such as seizures, stroke, or memory loss)
Lung or breathing problems
Heart problems
Liver problems
Kidney problems
A recent or active infection

Tell your healthcare provider about all the medications you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

How will I receive YESCARTA?

Since YESCARTA is made from your own white blood cells, your blood will be collected by a process called “leukapheresis” (loo-kah-fur-ee-sis), which will concentrate your white blood cells.
Your blood cells will be sent to a manufacturing center to make your YESCARTA.
Before you get YESCARTA, you will get 3 days of chemotherapy to prepare your body.
When your YESCARTA is ready, your healthcare provider will give it to you through a catheter placed into your vein (intravenous infusion). The infusion usually takes less than 30 minutes.
You will be monitored where you received your treatment daily for at least 7 days after the infusion.
You should plan to stay close to the location where you received your treatment for at least 4 weeks after getting YESCARTA. Your healthcare provider will help you with any side effects that may occur.
You may be hospitalized for side effects and your healthcare provider will discharge you if your side effects are under control, and it is safe for you to leave the hospital.
Your healthcare provider will want to do blood tests to follow your progress. It is important that you do have your blood tested. If you miss an appointment, call your healthcare provider as soon as possible to reschedule.

What should I avoid after receiving YESCARTA?

Do not drive, operate heavy machinery, or do other dangerous things for 8 weeks after you get YESCARTA because the treatment can cause sleepiness, confusion, weakness, and temporary memory and coordination problems.
Do not donate blood, organs, tissues, or cells for transplantation.

What are the possible or reasonably likely side effects of YESCARTA?

The most common side effects of YESCARTA include:

Fever (100.4°F/38°C or higher)
Low white blood cells (can occur with a fever)
Low red blood cells
Low blood pressure (dizziness or lightheadedness, headache, feeling tired, short of breath)
Fast heartbeat
Confusion
Difficulty speaking or slurred speech
Nausea
Diarrhea

These are not all the possible side effects of YESCARTA. Call your healthcare provider about any side effects that concern you. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1‑800‑FDA‑1088.

Please see the Important Facts, including IMPORTANT WARNINGS.

APPROVED USE

YESCARTA is a prescription medicine used to treat two types of non-Hodgkin lymphoma:

large B-cell lymphoma when your first treatment did not work or your cancer returned within a year of first treatment, OR when at least two kinds of treatment have failed to control your cancer.
follicular lymphoma when at least two kinds of treatment have failed to control your cancer.

YESCARTA is different than other cancer medicines because it is made from your own white blood cells, which have been modified to recognize and attack your lymphoma cells.

Our response to COVID-19

Terms and conditions

Privacy policy

For help finding an Authorized Treatment Center or information about the support resources that may be available to you, call Kite Konnect at 1-844-454-KITE [5483], Monday–Friday, 5 am–6 pm PT.

Please note: Kite Konnect support may be subject to eligibility requirements and other terms and conditions. Contact Kite Konnect for more information.

Authorized Treatment Centers are independent facilities certified to dispense Kite CAR T therapies. Choice of an Authorized Treatment Center is within the sole discretion of the physician and patient. Kite does not endorse any individual treatment sites.

Resources may include referrals to independent third-party nonprofit patient assistance programs. These programs are not operated or controlled by Kite. Nonprofit patient assistance program eligibility requirements may vary and are established solely by each independent organization. Kite makes no guarantee with respect to reimbursement or copay assistance for any item or service.

Cell therapy programs are for eligible prescribed patients.

The content of this site is intended for US residents only.

YESCARTA, the Yescarta Logo, KITE KONNECT, the Kite Konnect Logo, KITE, and the Kite Logo are trademarks of Kite Pharma, Inc.
GILEAD is a trademark of Gilead Sciences, Inc. All other trademarks referenced herein are the property of their respective owners.